Medicare Enrolled
Dr. Dimitri Papagiannopoulos, M.D.
Urology Physician · Wheaton, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Papagiannopoulos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Papagiannopoulos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Papagiannopoulos
Dr. Dimitri Papagiannopoulos is an urology physician in Wheaton, IL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Papagiannopoulos performed 5,850 Medicare services across 2,068 unique beneficiaries.
Between the years covered by Open Payments, Dr. Papagiannopoulos received a total of $2,934 from 30 pharmaceutical and/or device companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Papagiannopoulos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 21% volume in IL
$2,934 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,850
Medicare services
Top 21% in IL for urology physician
2,068
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~418 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,250 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
657 | $96 | $228 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
570 | $2 | $20 |
| Leuprolide injectable, camcevi, 1 mg | 546 | $63 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
303 | $8 | $100 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
285 | $43 | $129 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $63 | $163 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
115 | $147 | $324 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
111 | $194 | $930 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
104 | $8 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $129 | $302 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
65 | $71 | $530 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
62 | $40 | $154 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $66 | $140 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
43 | $20 | $580 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
39 | $73 | $177 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
31 | $49 | $340 |
| New patient office visit, complex (60-74 min) | 29 | $167 | $400 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
27 | $112 | $590 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $358 | $1,800 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $128 | $2,140 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $112 | $1,010 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $27 | $560 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
19 | $29 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $109 | $260 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $47 | $103 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
16 | $6 | $240 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
16 | $107 | $243 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $20 | $42 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $273 | $1,130 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $616 | $3,670 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
11 | $223 | $1,240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
7.0% medium
92.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,934
Total received (2018-2024)
Avg $419/year across 7 years
Top 43% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
128
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,934 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$715
2023
$845
2022
$265
2021
$355
2020
$31
2019
$106
2018
$617
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$211
Boston Scientific Corporation
$152
C. R. Bard, Inc. & Subsidiaries
$72
Janssen Biotech, Inc.
$63
ACCORD HEALTHCARE, INC.
$45
ABBVIE INC.
$36
PROCEPT BioRobotics Corporation
$34
Tempus AI, Inc
$29
Bayer Healthcare Pharmaceuticals Inc.
$20
Teleflex LLC
$19
Sumitomo Pharma America, Inc.
$19
Merck Sharp & Dohme LLC
$16
Top 3 companies account for 60.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$481
Coloplast Corp
$373
BOSTON SCIENTIFIC CORPORATION
$355
Dendreon Pharmaceuticals LLC
$333
C. R. Bard, Inc. & Subsidiaries
$125
Cook Incorporated
$121
ABBVIE INC.
$108
KARL STORZ Endoscopy-America
$96
DENTSPLY IH Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$90
Janssen Biotech, Inc.
$78
Philips Electronics North America Corporation
$74
Sumitomo Pharma America, Inc.
$63
Astellas Pharma US Inc
$53
ConvaTec Inc.
$52
Antares Pharma, Inc.
$47
ACCORD HEALTHCARE, INC.
$45
Axonics, Inc.
$43
Endo Pharmaceuticals Inc.
$42
Teleflex LLC
$37
PROCEPT BioRobotics Corporation
$34
Myriad Genetic Laboratories, Inc.
$33
UroGen Pharma, Inc.
$31
Tempus AI, Inc
$29
Retrophin, Inc.
$19
TOLMAR Pharmaceuticals, Inc.
$19
Cook Medical LLC
$17
NeoTract Inc.
$16
Merck Sharp & Dohme LLC
$16
AngioDynamics, Inc.
$16
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 09 PROMO FLEX-X FLEX URETEROSCOPE · 7.5F · AMS · AQUABEAM SYSTEM · ASCERTA · Axonics · Bard Urinary Drainage Bag · CAMCEVI · COOK MEDICAL UROLOGY · ELIGARD · ERLEADA · FIBER DUST · GEMTESA · GENERAL BPH · GENTLECATH · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · LoFric · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · REZUM · SpeediCath · URETERAL SYSTEM · UROLIFT · UroLift · Uronav · XIAFLEX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
276
Per 100K population
29.8
County median income
$110,502
Nearest hospital
NORTHWESTERN MEDICINE CENTRAL DUPAGE HOSPITAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Papagiannopoulos is a clinical cardiology specialist, with above-average Medicare volume (top 21% in IL), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Papagiannopoulos experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Papagiannopoulos performed 2,250 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Papagiannopoulos receive payments from pharmaceutical companies?
Yes. Dr. Papagiannopoulos received a total of $2,934 from 30 companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Papagiannopoulos's costs compare to other urology physicians in Wheaton?
Dr. Papagiannopoulos's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Papagiannopoulos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wheaton
Browse urology physicians in Wheaton ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology